Knowledge Center

Article / Jan 01, 2012

Carcinogenic pollutants in drug manufacturing

Authors:
  • Gyorgy Szekely
  • William Heggie
  • Boerje Sellergren
Source:
Magyar Kemikusok Lapja (2012), 67(2), 34-37

A review.

Also in the Knowledge Center

Related Content

Inspections History

ËÄÉ«AV sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more

Particle Engineering for Inhalation and Nasal

ËÄÉ«AV is a global expert and recognized leader in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more

Dry Powder Inhalation formulation development

ËÄÉ«AV has considerable inhalation experience that allows us to implement strategies including conventional carrier based, neat (drug-alone) or composite particle formulations.

Page
Read more